Brian Adams

2017 - Keryx Biopharmaceuticals

In 2017, Brian Adams earned a total compensation of $1.2M as Former General Counsel and Secretary at Keryx Biopharmaceuticals, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$139,730
Option Awards$386,042
Salary$366,988
Stock Awards$269,588
Other$5,672
Total$1,168,020

Adams received $386K in option awards, accounting for 33% of the total pay in 2017.

Adams also received $139.7K in non-equity incentive plan, $367K in salary, $269.6K in stock awards and $5.7K in other compensation.

Rankings

In 2017, Brian Adams' compensation ranked 8,227th out of 14,666 executives tracked by ExecPay. In other words, Adams earned more than 43.9% of executives.

ClassificationRankingPercentile
All
8,227
out of 14,666
44th
Division
Manufacturing
3,108
out of 5,772
46th
Major group
Chemicals And Allied Products
1,023
out of 2,075
51st
Industry group
Drugs
805
out of 1,731
54th
Industry
Pharmaceutical Preparations
631
out of 1,333
53rd
Source: SEC filing on May 31, 2018.

Adams' colleagues

We found four more compensation records of executives who worked with Brian Adams at Keryx Biopharmaceuticals in 2017.

2017

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

2017

Christine Carberry

Keryx Biopharmaceuticals

Chief Operating Officer

2017

John Neylan

Keryx Biopharmaceuticals

Chief Medical Officer

2017

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

News

You may also like